|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| Novavax, Inc. - SWOT Analysis |
|
|
|
|
€ 100,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Juillet 2007 |
Taille du document : |
20 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 48 pages | Mars 1999 | Anglais
|
|
|
| Main
focus: |
vaccines,vaccine,hepatitis b,immunology,...,...
|
| Research
focus: |
market outlook,demand analysis,industry structure, |
| Geographic
focus: |
usa,france,united kingdom,canada,switzerland,japan,... |
| |
|
|
|
|
| 118 pages | Décembre 2002 | Anglais
|
|
|
| Main
focus: |
health care,vaccines,vaccine,hepatitis b,...
|
| Research
focus: |
industry structure,market definition, |
| Geographic
focus: |
india,usa,switzerland,france,united kingdom,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Signal Transduction
170 pages | Décembre 2000 |
Novel drug targets are emerging from the elucidation of the molecular chain reactions that underlie the responses of cells to their environment.
Signal transduction is the term describing the p |
1 400,00 €
|
| |
| |
Bioinformatics
150 pages | Décembre 2000 |
Automation has assaulted several levels of biological research generating vast amounts of data.
Great leaps in DNA sequencing technology and automation led to a dramatic increase in sequence th |
1 400,00 €
|
| |
| |
03-010: The Market for Toxicogenomics Products & Services
193 pages | Avril 2003 |
This report provides a look at service providers, informatics products, microarrays and databases from the end-user's perspective |
640,00 €
|
| |
| |
03-011: The Market for Real-Time PCR Reagents & Instrumentation
180 pages | Avril 2003 |
Based on a detailed 52-question survey of 406 scientists who currently perform qPCR, this report describes their research interests and specific applications |
640,00 €
|
| |
| |
03-018: Market Opportunities in Cytokine & Growth Factor Research
170 pages | Mai 2003 |
This report identifies preferred quantification and activity assays, new research trends and the most popular suppliers of antibodies, recombinant proteins and DNA microarrays |
800,00 €
|
| |
| |
Pharmacogenomics
160 pages | Décembre 2000 |
The Human Genome Project and numerous corporate and academic human gene sequencing efforts have revealed, among others, that genes exist in the population in numerous mutated forms, some of which |
1 400,00 €
|
| |
| |
NanoBioTechnology: Trends and Technological Developments
18 pages | Février 2003 |
Nanobiotechnology is being projected as a great scientific and technological opportunity for the Bio world.
It is widely recognized as one of the most beneficial areas of nanotechnology to industry |
450,00 €
|
| |
| |
Biotech Industry Potential: Emerging Markets & Trends
15 pages | Novembre 2002 |
The global biotech industry is comprised of 4,284 companies in 25 nations.
The 622 public companies generated revenues of $35 billion, spent $16 billion in R&D and employed more than 188,000 people |
250,00 €
|
| |
| |
Functional Proteomics and Emerging Bio-IT market
pages | Novembre 2002 |
The proteomic technique is not only limited to the study of one or few cellular products but also allows for qualitative and a quantitative measurement of several hundreds of proteins produced during |
250,00 €
|
| |
| |
Pharmacogenomics IRCD
pages | Juillet 2001 |
The Human Genome Project and numerous corporate and academic human gene sequencing efforts have revealed, among others, that genes exist in the population in numerous mutated forms, some of which are |
1 200,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Novavax, Inc. - SWOT Analysis |
|
|
Datamonitor's Novavax, Inc. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Novavax is a biopharmaceuticl company focused on the development and licensing of vaccines against the H5N1, H9N2 and other subtypes of avian influenza with pandemic potential as well as vaccines that protect against seasonal influenza. The company primarily operates in the US. The company is headquartered in Rockville, Maryland and employs approximately 60 people. The company recorded revenues of $4.7 million during the fiscal year ended December 2006, a decrease of 36.6% over 2005. The operating loss of the company was $24.6 million during fiscal year 2006 as compared to an operating loss of $9.1 million in the year 2005. The net loss was $23.1 million in fiscal year 2006 as compared to a net loss of $11.1 million during the fiscal year 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
Table of Contents:
This product typically includes the following sections:
Key Facts
Company Overview
Business Description
Company History
Key Employees
Key Employee Biographies
Company View
SWOT analysis
Products & Services Listing
Products & Services Analysis
|
|
|
PPLSEN
|
|
|
|
|
